$20.47
-0.08-0.39%
At Close: -
$20.21
-0.26-1.27%
After Hours: 6:33 PM EDT
15 minutes delayed
Catalyst Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Catalyst Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $0.56 | $0.26 | 115.4 % |
Mar 2024 | 2024-05-08 | $0.38 | $0.17 | 123.5 % |
Dec 2023 | 2024-02-28 | $0.53 | $0.26 | 103.8 % |
Sep 2023 | 2023-11-08 | $0.49 | $0.44 | 11.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $122.71M | $111.96M | 9.60 % |
Mar 2024 | 2024-05-08 | $98.51M | $98.13M | 0.39 % |
Sep 2023 | 2023-11-08 | $102.69M | $100.38M | 2.30 % |
Jun 2023 | 2023-08-09 | $99.58M | $92.73M | 7.39 % |
Catalyst Pharmaceuticals (CPRX) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $0.56, which beat the estimate of $0.26.
The Actual Revenue was $122.7M, which beat the estimate of $112M.
Browse earnings estimates, EPS, and revenue on all stocks.